The top regulatory health authority of Brazil banned Sputnik V, a Chinese coronavirus vaccine candidate developed by Russia, on Wednesday citing, among other flaws, that samples it studied contained a live virus that causes respiratory illness.
Brazil’s National Health Surveillance Agency (Anvisa) also asserted that Russia’s Gamaleya Institute, which produced the vaccine candidate, did not provide “consistent and reliable data” on the efficacy of Sputnik V.
Sputnik V was the first vaccine candidate for use against any coronavirus approved for widespread use by a large country. Russian leader Vladimir Putin personally approved the distribution of the vaccine candidate in the country in August 2020 despite it not yet having completed the typically necessary Phase III of clinical trials. Putin has no known medical background. While he claims to have been vaccinated against coronavirus, he has not disclosed if he chose Sputnik V or one of the several other products available that